Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2019

Jul 11, 2019

31996_dirs_2019-07-10_39903624-3a37-4ca8-bd79-3e9edd995f8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2019-06-27

Reporting Person: Barnes Scott D (Chief Medical Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1368 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Common Stock Options $15.25 2027-11-12 Common Stock Options (25000) Direct
Common Stock Options $16.15 2028-03-14 Common Stock Options (12500) Direct
Common Stock Options $29.80 2028-06-13 Common Stock Options (6742) Direct
Common Stock Options $35.98 2029-03-13 Common Stock Options (30894) Direct

Footnotes

F1: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (11/13/2017) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F2: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/15/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F3: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (6/14/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F4: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/14/2019) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.